Thursday June 30, 2022 at 11am ET | 10am CT | 8am PT
Cell and gene therapy (CGT) and antibody-drug conjugate (ADC) developers and manufacturers discuss factors that could influence organizations to pursue specific biomolecules for development. Pharmaceutical Technology editors interview experts in CGTs and ADCs in this episode of the Drug Digest video series.
